VNIM
HAE icon

Vaughan Nelson Investment Management’s Haemonetics HAE Stock Holding History

Vaughan Nelson Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-565,825
Closed -$23.4M – 163
2015
Q2 		$23.4M Sell
565,825
-220,350
-28% -$9.29M 0.33% 120
2015
Q1 		$35.3M Sell
786,175
-967,325
-55% -$40.4M 0.54% 79
2014
Q4 		$65.6M Buy
1,753,500
+210,950
+14% +$7.73M 0.96% 42
2014
Q3 		$53.9M Buy
1,542,550
+237,800
+18% +$8.49M 0.81% 57
2014
Q2 		$46M Buy
+1,304,750
New +$43.6M 0.65% 64

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vaughan Nelson Investment Management's HAE Position: Q3 2015 in Review

Vaughan Nelson Investment Management sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 565,825 shares — an estimated $23.4M sold.

Vaughan Nelson Investment Management first reported a position in HAE in Q2 2014 and held it in 5 quarters. The position peaked at $65.6M in Q4 2014. 171 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

  • Vaughan Nelson Investment Management reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 565,825 Haemonetics shares in Q3 2015, an estimated $23.4M.
  • Vaughan Nelson Investment Management first reported a position in Haemonetics in Q2 2014 and held it in 5 quarters.
  • Vaughan Nelson Investment Management's Haemonetics position peaked at $65.6M in Q4 2014.
  • 171 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on Vaughan Nelson Investment Management's 13F filing for Q3 2015, filed 5 Nov 2015.